Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal for STEM Education Research
|
November 23, 2020
Results from a 14-Year Intervention Program Designed to Impact Pursuit of a PhD in Research among Underrepresented Students in STEM Disciplines
Gretchen Schneider Burton, Eugene Kennedy, Maria da Graça H Vicente
Journal of Neuro-Oncology
|
November 12, 2018
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod
Rimas V Lukas, Csaba Juhász, Derek A Wainwright, et al.
Ethnicity & Disease
|
November 8, 2007
Cultural characteristics of African Americans: implications for the design of trials that target behavior and health promotion programs
Betty M Kennedy, Jamy D Ard, Louis Harrison, et al.
The Oncologist
|
February 12, 2020
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Andrew W Hahn, Charles Drake, Samuel R Denmeade, et al.
Advances in Radiation Oncology
|
December 16, 2024
Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis
Carryn Anderson, Samuel Salvaggio, Mickaël De Backer, et al.
JAMA Oncology
|
November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial
Veronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.
Annals of Surgery
|
February 25, 2021
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Daniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, et al.
Immunity
|
October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
JAMA Oncology
|
September 19, 2024
Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial
Naifei Chen, Chengfei Pu, Lingling Zhao, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal for STEM Education Research
|
November 23, 2020
Results from a 14-Year Intervention Program Designed to Impact Pursuit of a PhD in Research among Underrepresented Students in STEM Disciplines
Gretchen Schneider Burton, Eugene Kennedy, Maria da Graça H Vicente
Journal of Neuro-Oncology
|
November 12, 2018
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod
Rimas V Lukas, Csaba Juhász, Derek A Wainwright, et al.
Ethnicity & Disease
|
November 8, 2007
Cultural characteristics of African Americans: implications for the design of trials that target behavior and health promotion programs
Betty M Kennedy, Jamy D Ard, Louis Harrison, et al.
The Oncologist
|
February 12, 2020
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Andrew W Hahn, Charles Drake, Samuel R Denmeade, et al.
Advances in Radiation Oncology
|
December 16, 2024
Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis
Carryn Anderson, Samuel Salvaggio, Mickaël De Backer, et al.
JAMA Oncology
|
November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial
Veronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.
Annals of Surgery
|
February 25, 2021
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Daniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, et al.
Immunity
|
October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
JAMA Oncology
|
September 19, 2024
Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial
Naifei Chen, Chengfei Pu, Lingling Zhao, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Page
of 2